pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,885 catalysts · 4,876 phase readout · 2,348 8k filing · 286 earnings · 275 pdufa · 166 phase 2 completion · 71 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 10 catalysts2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: patent expiry×type: phase readout×clear all
type
  • phase readout4,876
  • 8k filing2,348
  • earnings286
  • pdufa275
  • phase 2 completion166
  • phase 1 completion71
phase 2 initiation
54
  • phase 1 initiation39
  • phase 1 2 completion33
  • phase 0 trial completion23
  • therapy area
    • Infectious Disease7
    • Dermatology1
    • Oncology1

    Date TBD

    50
    ›RECRUITINGphase readoutNCT04685200: Unraveling the Mechanisms Underlying Primary Sclerosing Cholangitis Through a Multidisciplinary, Integrative Research Approach

    Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Phase: . Conditions: Primary Sclerosing Cholangitis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07245407: A Translational Study for Phenotyping and Endotyping Chinese Patients With NCFBE

    Sponsor: AstraZeneca. Phase: . Conditions: Non-cystic Fibrosis Bronchiectasis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04804007: Maintenance Oral Etoposide or Observation Following High-dose Chemo for GCT

    Sponsor: Nabil Adra. Phase: PHASE2. Conditions: Germ Cell Tumor, Non-seminomatous Germ Cell Tumor, Ovarian Germ Cell Tumor

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07147192: Feasibility Study of an Accommodating IOL Design

    Sponsor: Alcon Research. Phase: NA. Conditions: Aphakia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07363811: Large Granular Lymphocytes in mNSCLC Treated With Nivolumab

    Sponsor: Necmettin Erbakan University. Phase: . Conditions: Metastatic NSCLC - Non-Small Cell Lung Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01766271: GENErating Behavior Change, An Integrative Health Coaching and Genetic Risk Testing Pilot

    Sponsor: Duke University. Phase: NA. Conditions: Coronary Heart Disease Risk

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07577700: Assessment of Pulmonary Perfusion and Hemodynamic Measurements by Electrical Impedance Tomography in Patients Undergoing Pulmonary Thromboendarterectomy.

    Sponsor: University of Sao Paulo General Hospital. Phase: NA. Conditions: Pulmonary Thromboendarterectomy, Pulmonary Embolism and Thrombosis

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07546344: Peer-led Service Delivery Model for Pregnant and Lactating Adolescent Girls and Young Women in Zimbabwe

    Sponsor: University College, London. Phase: NA. Conditions: HIV Prevention, Contraceptive Usage, Adherence, Medication

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07499544: A Phase III Study to Evaluate the Efficacy and Safety of Libevitug in Participants With Chronic HDV Infection (D-clear Study)

    Sponsor: Huahui Health. Phase: PHASE3. Conditions: Chronic Hepatitis D Infection

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07590934: Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer

    Sponsor: AstraZeneca. Phase: PHASE1. Conditions: Metastatic Prostate Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06648434: MK2 Inhibitor in Combination With mFOLFIRINOX for Untreated Metastatic Pancreatic Ductal Adenocarcinoma

    Sponsor: Washington University School of Medicine. Phase: PHASE1. Conditions: Metastatic Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer, Cancer of the Pancreas

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06196034: Genetic Association With Various Severities, Phenotypes and Endotypes of Asthma.

    Sponsor: Chinese University of Hong Kong. Phase: . Conditions: Asthma

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT05317364: Topical Vaginal Estrogen for Postpartum Obstetric Anal Sphincter Injury Recovery

    Sponsor: University of Alabama at Birmingham. Phase: PHASE4. Conditions: Obstetric; Injury Pelvic Floor, Sexual Dysfunction, Anal Incontinence, Urinary Incontinence

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07381764: ROMANCE: "Irinotecan Plus Cetuximab Rechallenge Versus Trifluridine/Tipiracil Plus Bevacizumab in Molecularly Selected Metastatic Colorectal Cancer"

    Sponsor: Gruppo Oncologico Italia Meridionale. Phase: PHASE2. Conditions: Metastatic Colorectal Cancer (CRC)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07446764: Integrated Health Services (IHS): A Structural Intervention to Improve HIV/STI Screening and PrEP Navigation in Primary Care

    Sponsor: My Brother's Keeper, Inc.. Phase: NA. Conditions: HIV, STDs

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07362264: A Study of SH006 Injection Combination Therapy in Patients With Advanced Solid Tumors

    Sponsor: Nanjing Sanhome Pharmaceutical, Co., Ltd.. Phase: PHASE1. Conditions: Liver Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07480564: Safety and Preliminary Efficacy of TSHA-102 Gene Therapy in Pediatric Females Aged >2 to <4 Years With Rett Syndrome

    Sponsor: Taysha Gene Therapies, Inc.. Phase: PHASE3. Conditions: Rett Syndrome

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07572409: Application of Cardiophrenic Lymphadenectomy in Advanced Ovarian Cancer: A Single-Center Prospective Exploratory Study

    Sponsor: manxiaxia. Phase: NA. Conditions: Ovarian Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06503809: Efficacy and Safety of a Ketogenic Diet in Type 1 Diabetes

    Sponsor: Washington University School of Medicine. Phase: NA. Conditions: Diabetes Mellitus, Type 1

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07006532: Treatment of Chronic Active Antibody Mediated Rejection With Tocilizumab

    Sponsor: Shahid Beheshti University of Medical Sciences. Phase: NA. Conditions: Kidney Transplant Rejection

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05927532: Argyle Safety Fistula Cannula With Anti-reflux Valve Clinical Study

    Sponsor: Mozarc Medical US LLC. Phase: NA. Conditions: End Stage Renal Failure on Dialysis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07499232: A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

    Sponsor: Janssen Research & Development, LLC. Phase: PHASE3. Conditions: Crohn Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07003698: Postoperative Analgesic Efficacy of Recto Intercostal Nerve Block

    Sponsor: Ankara Etlik City Hospital. Phase: NA. Conditions: Laparoskopic Cholecystectomy, Recto Intercostal Nerve Block

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05169398: EUS-guided Hepatico-gastrostomy Using a Novel Lumen Apposing Metal Stent

    Sponsor: Chinese University of Hong Kong. Phase: NA. Conditions: Malignant Biliary Obstruction

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04781621: Foundational Ingredients of Robotic Gait Training for People With Spinal Cord Injury During Inpatient Therapy

    Sponsor: Baylor Research Institute. Phase: NA. Conditions: Spinal Cord Injuries

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03711214: Immune Profile of Saliva and Serum of Patients With Primary Sjögren´s Syndrome

    Sponsor: University of Sao Paulo General Hospital. Phase: NA. Conditions: Sjogren's Syndrome

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04829604: ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03)

    Sponsor: Ambrx, Inc.. Phase: PHASE2. Conditions: HER2 Positive Metastatic Breast Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05451004: SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer

    Sponsor: Canadian Cancer Trials Group. Phase: PHASE3. Conditions: Oropharyngeal Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07286604: Ivermectin Repurposed for the Treatment of PKDL

    Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh. Phase: EARLY_PHASE1. Conditions: Post Kala Azar Dermal Leishmaniasis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05235204: Early Foley Catheter Removal After Diverticular Colovesical Fistula Repair

    Sponsor: Karim Alavi. Phase: NA. Conditions: Colovesical Fistula

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04371484: Proposal of a Method Using the PMSI and SNIIRAM National Databases to Estimate the Frequency of Physical Abuse and to Identify th Eassociated At-risk Situations and Consequences in Children Aged 0 to 5 Years in France

    Sponsor: Centre Hospitalier Universitaire Dijon. Phase: . Conditions: Child Abuse

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03921684: Trial of Nivolumab With FOLFOX After Chemoradiation in Rectal Cancer Patients

    Sponsor: Baruch Brenner. Phase: PHASE2. Conditions: Rectal Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07319052: β-Alanine for Kickboxing Anaerobic Performance

    Sponsor: Salih ÇABUK. Phase: NA. Conditions: Athletic Performance Enhancement (Kickboxing), Anaerobic Performance, Strength Endurance, Neuromuscular Power, Nutritional Supplementation (β-Alanine)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05610852: Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound

    Sponsor: Case Comprehensive Cancer Center. Phase: NA. Conditions: Prostate Adenocarcinoma, Prostate Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06372249: A Clinical Trial of Soluble Fiber for Asthma

    Sponsor: Phoenix Children's Hospital. Phase: PHASE2. Conditions: Asthma in Children

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT05318638: Soft-robotic Glove Support of High-demand Tasks

    Sponsor: Roessingh Research and Development. Phase: NA. Conditions: Neuromuscular Diseases, Sarcopenia

    full page →ctgov ↗
    ›WITHDRAWNphase readoutNCT06023238: Knee Prosthetic Joint Infection Antibiotic Elution

    Sponsor: University of Pittsburgh. Phase: . Conditions: Prosthetic-joint Infection, Arthroplasty Complications

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07239258: The Effects of Mir Shakeel Teleintegrated Therapy Plan in Patients Undergoing Total Knee Arthroplasty

    Sponsor: Lincoln University College. Phase: NA. Conditions: Total Knee Anthroplasty, Total Knee Arthroplasty Recovery

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05757778: Split Chest Breast Neurotization

    Sponsor: NYU Langone Health. Phase: NA. Conditions: Breast Implant; Complications

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07123285: Effect of Photobiomodulation on Healing of Venous Leg Ulcers

    Sponsor: University of Nove de Julho. Phase: NA. Conditions: Venous Disease, Venous Insufficiency (Chronic)(Peripheral), Venous Insufficiency of Leg, Venous Leg Ulcer (VLU), Venous Leg Ulcer, Venous Hypertension Ulcers, Varicose Ulcers, Varicose Ulcer of Lower Limb

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05733585: Clinical Study of Patients Treated With PuraBond Haemostatic Agent During Abdominal Aorta Open Repair

    Sponsor: IRCCS San Raffaele. Phase: . Conditions: Hemostatic

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07534085: Effects of a Structured Physical Activity Program on Balance and Functional Performance in Children With Down Syndrome

    Sponsor: Ankara University. Phase: NA. Conditions: Down Syndrome (DS), Balance Assessment, Physical Activities, Yoga, Rehabilitation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05806645: UPTAKE: Using Personalized Risk and Digital Tools to Guide Transitions Following Acute Kidney Events

    Sponsor: University of Alberta. Phase: NA. Conditions: Acute Kidney Injury

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07118345: Early Prophylactic Decompressive Hemicraniectomy Following Endovascular Therapy in Large Hemispheric Infarct Trial

    Sponsor: Xuanwu Hospital, Beijing. Phase: NA. Conditions: Stroke, Ischemic, Cerebral Edema

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06578195: ASSESS ALL ALS Study

    Sponsor: St. Joseph's Hospital and Medical Center, Phoenix. Phase: . Conditions: Amyotrophic Lateral Sclerosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT02526095: The French EsoGastricTumours Data Base

    Sponsor: University Hospital, Lille. Phase: . Conditions: Esophageal Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07351695: Assessment of Nutritional Status Using Mid-Upper Arm Circumference Z-Score in Children With Cerebral Palsy

    Sponsor: Muğla Sıtkı Koçman University. Phase: . Conditions: Cerebral Palsy (CP), Malnutrition in Children

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04888039: Follow-up of Patients With Multiple Myeloma in the West-Occitanie Region "Living With a Myeloma in West-Occitanie"

    Sponsor: University Hospital, Toulouse. Phase: . Conditions: Multiple Myeloma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06603077: A Study to Evaluate the Efficacy and Safety of AVTX-009 in Patients With Moderate to Severe Hidradenitis Suppurativa

    Sponsor: Avalo Therapeutics, Inc.. Phase: PHASE2. Conditions: Hidradenitis Suppurativa

    full page →ctgov ↗
    ›AVAILABLEphase readoutNCT07310277: Expanded Access to ABBV-706

    Sponsor: AbbVie. Phase: . Conditions: Small Cell Lung Cancer

    full page →ctgov ↗
    ← prev
    page 34 of 98
    next →